FDA Mandates Major Opioid Label Revisions to Highlight Long-Term Risks
Pharmacy Times
AUGUST 7, 2025
Suggestions for providers featured in the guidelines include determining if opioids should take place, selecting appropriate dosages, determining prescription length and follow-up, and assessing and reducing risks of misuse, overdose, and opioid use disorder.
Let's personalize your content